“…Eosinophils produce and store many biologically active molecules in their granules, including eosinophil peroxidase (EPX), eosinophil cationic protein (ECP), eosinophil major basic protein 1 (eMBP1), major basic protein 2, and numerous cytokines, including TGF‐ß (Table S2 ). 12 , 13 , 14 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 In the setting of massive and persistent eosinophil activation, eosinophil‐derived (toxic) substances can cause substantial changes in the local microenvironment, resulting in organ damage, often in association with local inflammation, cytotoxicity, thromboembolic complications, and/or fibrosis. 1 , 2 , 3 , 12 , 13 , 14 , 42 , 43 , 44 In patients with tissue HE and persistent eosinophil activation, marked deposition of eosinophil granule proteins, including eMBP1 and EPX, is usually found although staining for these eosinophil‐derived proteins is not standardized or available in most centers.…”